MedPath

郑州瑞星药业有限公司

Ownership
-
Established
2000-08-04
Employees
-
Market Cap
-
Website
www.ruixingyaoye.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

NMPA:8

Drug Approvals

小儿咳喘灵颗粒

Approval Number
国药准字Z41020482
Approval Date
Apr 7, 2025
NMPA

脑乐静

Approval Number
国药准字Z20113078
Approval Date
Jan 11, 2024
NMPA

三甲散

Approval Number
国药准字Z41020483
Approval Date
May 25, 2020
NMPA

板蓝根颗粒

Approval Number
国药准字Z41020484
Approval Date
May 25, 2020
NMPA

生脉饮

Approval Number
国药准字Z41020485
Approval Date
May 25, 2020
NMPA

小儿咳喘灵口服液

Approval Number
国药准字Z41020486
Approval Date
May 25, 2020
NMPA

清热解毒口服液

Approval Number
国药准字Z20027748
Approval Date
May 25, 2020
NMPA

冬凌草糖浆

Approval Number
国药准字Z41022340
Approval Date
May 25, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.